Skip to main content
TipRanks
Go Ultimate75% OFF

Luye Pharma Group (2186) Income Statement

3 Followers

Luye Pharma Group Income Statement

Last quarter (Q2 2026), Luye Pharma Group's total revenue was ¥3.00B, a decrease of 2.36% from the same quarter last year. In Q2, Luye Pharma Group's net income was ¥390.49M. See Luye Pharma Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 6.31B¥ 6.06B¥ 6.14B¥ 5.98B¥ 5.20B
¥ 4.16B¥ 4.04B¥ 4.20B¥ 4.14B¥ 3.40B
¥ 2.92B¥ 2.90B¥ 3.29B¥ 3.26B¥ 2.96B
Depreciation and Amortization¥ 839.49M¥ 790.67M¥ 701.85M¥ 671.31M¥ 581.98M
¥ 2.06B¥ 1.92B¥ 2.08B¥ 1.81B¥ 906.88M
¥ 1.24B¥ 1.15B¥ 917.88M¥ 880.62M¥ 437.96M
¥ -298.24M¥ -308.03M¥ -217.78M¥ -210.86M¥ -357.36M
¥ 944.64M¥ 839.22M¥ 700.10M¥ 669.76M¥ -74.56M
¥ 618.75M¥ 471.89M¥ 532.61M¥ 604.81M¥ -134.39M
Per Share Metrics
Basic EPS¥ 0.16¥ 0.13¥ 0.14¥ 0.17¥ -0.04
Diluted EPS¥ 0.16¥ 0.13¥ 0.14¥ 0.17¥ -0.04
Weighted Average Shares Outstanding3.90B3.76B3.73B3.48B3.45B
Weighted Average Shares Outstanding (Diluted)3.90B3.76B3.73B3.48B3.45B

Currency in CNY

Luye Pharma Group Earnings and Revenue History

-4B04B8B-15 %0 %15 %30 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin